SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30

$32.88−0.44 (-1.32%)

Close on Nov 13, 2026Market cap $1.10BP/E –Yield –

SpyGlass Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

SpyGlass Pharma's enterprise value was $946.47M on Nov 11, 2026.

Period	Period end	Value	Change
2026	Nov 11, 2026	$946.47M	–

See a number that looks wrong?